Radiology, Vol 157, 137-141, Copyright © 1985 by Radiological Society of North America

ARTICLES

Wilson disease of the brain: MR imaging

AM Aisen, W Martel, TO Gabrielsen, GM Glazer, G Brewer, AB Young and G Hill

Twenty-three patients with biochemically proved Wilson disease underwent magnetic resonance (MR) imaging of the brain. Positive findings, believed secondary to this condition, were found in 15 subjects. Findings varied among patients, but there were striking similarities between certain groups of patients. Areas of abnormal signal were seen in the lenticular, thalamic, caudate, and dentate nuclei, as well as in the brain stem; in these areas, the abnormalities were bilaterally symmetric. A smaller number of patients had asymmetric focal white-matter lesions. Correlation of the MR findings with clinical symptoms was generally good. Repeat imaging was performed on five patients at intervals ranging from 4 to 8 months; none showed significant interval change.

This article has been cited by other articles:

				K. J. Klos, J. E. Ahlskog, N. Kumar, S. Cambern, J. Butz, M. Burritt, R. D. Fealey, C. T. Cowl, J. E. Parisi, and K. A. Josephs Brain metal concentrations in chronic liver failure patients with pallidal T1 MRI hyperintensity Neurology, December 12, 2006; 67(11): 1984 - 1989. [Abstract] [Full Text] [PDF]

				D. Aikath, A. Gupta, I. Chattopadhyay, M. A. Hashmi, P. K. Gangopadhyay, S. K. Das, and K. Ray Subcortical white matter abnormalities related to drug resistance in Wilson disease. Neurology, September 12, 2006; 67(5): 878 - 880. [Abstract] [Full Text] [PDF]

				T.J. Kim, I.O. Kim, W.S. Kim, J.E. Cheon, S.G. Moon, J.W. Kwon, J.K. Seo, and K.M. Yeon MR Imaging of the Brain in Wilson Disease of Childhood: Findings Before and After Treatment with Clinical Correlation AJNR Am. J. Neuroradiol., June 1, 2006; 27(6): 1373 - 1378. [Abstract] [Full Text] [PDF]

				P. Favrole, H. Chabriat, J. P. Guichard, and F. Woimant Clinical correlates of cerebral water diffusion in Wilson disease Neurology, February 14, 2006; 66(3): 384 - 389. [Abstract] [Full Text] [PDF]

				L. T. Lucato, M. C. G. Otaduy, E. R. Barbosa, A. A. C. Machado, A. McKinney, L. A. Bacheschi, M. Scaff, G. G. Cerri, and C. C. Leite Proton MR Spectroscopy in Wilson Disease: Analysis of 36 Cases AJNR Am. J. Neuroradiol., May 1, 2005; 26(5): 1066 - 1071. [Abstract] [Full Text] [PDF]

				R.N. Sener Diffusion MR Imaging Changes Associated with Wilson Disease AJNR Am. J. Neuroradiol., May 1, 2003; 24(5): 965 - 967. [Abstract] [Full Text] [PDF]

				B Jeon, J M Kim, J M Jeong, K M Kim, Y S Chang, D S Lee, and M C Lee Dopamine transporter imaging with [123I]-beta -CIT demonstrates presynaptic nigrostriatal dopaminergic damage in Wilson's disease J. Neurol. Neurosurg. Psychiatry, July 1, 1998; 65(1): 60 - 64. [Abstract] [Full Text]

				M. Zeidler, R G Will, J W Ironside, R Sellar, and J Wardlaw Magnetic resonance imaging is not a sensitive test for Creutzfeldt-Jakob disease BMJ, March 30, 1996; 312(7034): 844 - 844. [Full Text]